Mrdds
Mrdds
SUBMITTED BY,
MONIKA S PATEL
1 SEM M. PHARM
ST
DEPARTMENT OF PHARMACEUTICS
SUBMITTED TO,
Dr. A . GEETHALAKSHMI
HOD and PROFESSOR
DEPARTMENT OF PHARMACEUTICS
HARSHA COLLEGE OF PHARMCY
Introduction
Advantages
Disadvantages
Physicochemical factros
Dose dumping.
Poor in vitro-in vivo correlation.
Increased instability.
Patient education is required for successful therapy.
Retrieval of drug is difficult in case of toxicity, poisoning or hypersensitivity
reactions.
Difficulty in dose adjustment.
1. Aqueous solubility
2. Partition coefficient
3. Drug stability
4. Dose size
5. Drug pka
6. Protein binding
• Partition coefficient is generally defined as the ratio of the fraction of drug in an oil phase to that of an
adjacent aqueous phase.
• It is common to consider that these membranes are lipidic therefore, the partition coefficient of oil-
soluble drugs becomes important in determining the effectiveness of membrane barrier penetration.
K=Co/Cw
Where, Co = Equilibrium concentration of all forms of the drug in an organic phase at equilibrium
Cw = Equilibrium concentration of all forms in an aqueous phase .
• High Partition Co efficient or High Lipophilicity of the drug readily penetrate the membrane but
unable to proceed further such drugs have increase tendency to cross even the more selective barriers
like BBB.
• Low Partition co efficient or High aqueous solubility of the drug cannot penetrate through membrane.
• Drugs undergo both basic /acidic hydrolysis and enzymatic degradation when administered oral route.
• Drugs showing stability problem in any particular area of GI tract are less suitable for controlled release
• The delivery system which is localized in a particular area of GI tract (Bio adhesive systems )act as
reservoir for drug release are much more suitable for these kind of drugs.
• CDDS is also suitable for drugs getting destroyed by enzymatic degradation via protection of drug by
• A very practical problem in construction of a sustained release dosage forms is the volume of the
• For orally administered systems, there is an upper limit to the bulk size of the dose to be
administered.
• In general, a single dose of 0.5±1.0 g is considered maximal for a conventional dosage form.
• This also holds for sustained-release dosage forms. Those compounds that require large dosing
size can sometimes be given in multiple amounts or formulated into liquid system
o pKa states that the uncharged form of a drug will be preferentially absorbed through many body
tissues.
o Drugs existing largely in an ionized form are poor candidates for oral SR DDS. --the absorption rate of
the ionized drug is 3-4 times less than that of the unionized drug.
• Protein binding characteristics of drug play a significant role in therapeutic effect regardless of
• The drug Protein complex serve as reservoir for controlled release of drugs to extra vascular
tissues.
• Extensive Protein binding will be evidenced by long half life for elimination and such drugs do